PFE: Pfizer Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 145,641.64
Enterprise Value ($M) 212,766.64
Book Value ($M) 87,975.00
Book Value / Share 15.52
Price / Book 1.66
NCAV ($M) -83,695.00
NCAV / Share -14.77
Price / NCAV -1.74

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 0.73
Current Ratio 1.00

Balance Sheet (mrq) ($M)
Current Assets 43,223.00
Assets 219,476.00
Liabilities 126,918.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 8.97 0.97
01-29 13G/A State Street Corp 5.10 1.03
01-26 13G/A BlackRock, Inc. 7.70 -1.83

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-12-06 5,479,246 25,183,185 21.76
2024-12-05 6,795,379 36,795,501 18.47
2024-12-04 8,575,748 31,678,771 27.07
2024-12-03 6,076,781 31,493,075 19.30

(click for more detail)

Similar Companies
NUVB – Nuvation Bio Inc. OGN – Organon & Co.
PBH – Prestige Consumer Healthcare Inc. PRGO – Perrigo Company plc
QGEN – Qiagen N.V.


Financial data and stock pages provided by
Fintel.io